Back to search

Article

Identification of novel therapeutic targets for polyglutamine toxicity disorders that target mitochondrial fragmentation

2021-10-20

Abstract excerpt

Huntington’s disease (HD) is one of at least nine polyglutamine toxicity disorders caused by a trinucleotide CAG repeat expansion, all of which lead to age-onset neurodegeneration. Mitochondrial dynamics and function are disrupted in HD and other polyglutamine toxicity disorders. While multiple studies have found beneficial effects from decreasing mitochondrial fragmentation in HD models by disrupting the mitochon...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4345c1c8-1a52-5f2c-beeb-83a30cba8050
DOI
10.1101/2021.10.19.465059
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of novel therapeutic targets for polyglutamine toxicity disorders that target mitochondrial fragmentationDOI 10.1101/2021.10.19.465059
Select a neighboring publication to make it the new centre.